453 related articles for article (PubMed ID: 17882360)
21. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S
Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149
[TBL] [Abstract][Full Text] [Related]
22. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
23. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
24. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
[TBL] [Abstract][Full Text] [Related]
25. [Blastoschizomyces capitatus fungemia: three case reports and review of the literature].
Gültekin B; Yavaşoğlu I; Eyigör M; Kadıköylü G; Bolaman Z; Aydın N
Mikrobiyol Bul; 2012 Jan; 46(1):134-43. PubMed ID: 22399183
[TBL] [Abstract][Full Text] [Related]
26. Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology.
Toriumi Y; Sugita T; Nakajima M; Matsushima T; Shinoda T
Microbiol Immunol; 2002; 46(2):89-93. PubMed ID: 11939583
[TBL] [Abstract][Full Text] [Related]
27. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
28. Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy.
O'Gorman C; McMullan R; Webb CH; Bedi A
Ulster Med J; 2006 Sep; 75(3):226-7. PubMed ID: 16964817
[No Abstract] [Full Text] [Related]
29. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
Kumar A; Udayakumaran S; Babu R; Rajamma BM; Prakash A; Panikar D; Karim S; Chowdhary A
Mycoses; 2015 Feb; 58(2):99-103. PubMed ID: 25590228
[TBL] [Abstract][Full Text] [Related]
30. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
31. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: first documented case from Greece.
Christakis G; Perlorentzou S; Aslanidou M; Megalakaki A; Velegraki A
Mycoses; 2005 May; 48(3):216-20. PubMed ID: 15842341
[TBL] [Abstract][Full Text] [Related]
32. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
[TBL] [Abstract][Full Text] [Related]
34. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Durán Graeff L; Seidel D; Vehreschild MJ; Hamprecht A; Kindo A; Racil Z; Demeter J; De Hoog S; Aurbach U; Ziegler M; Wisplinghoff H; Cornely OA;
Mycoses; 2017 Apr; 60(4):273-279. PubMed ID: 28150341
[TBL] [Abstract][Full Text] [Related]
35. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.
Arikan S; Hasçelik G
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):107-11. PubMed ID: 12088616
[TBL] [Abstract][Full Text] [Related]
36. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
37. Two possible cases of Trichosporon infections in bone-marrow-transplanted children: the first case of T. japonicum isolated from clinical specimens.
Ağirbasli H; Bilgen H; Ozcan SK; Otlu B; Sinik G; Cerikçioğlu N; Durmaz R; Can E; Yalman N; Gedikoğlu G; Sugita T
Jpn J Infect Dis; 2008 Mar; 61(2):130-2. PubMed ID: 18362402
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
Cong L; Liao Y; Yang S; Yang R
PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
[TBL] [Abstract][Full Text] [Related]
39. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
40. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
